Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8R8M

70S Escherichia coli ribosome with Paenilamicin B2 bound with hybrid A/P- and hybrid P/E-tRNA.

This is a non-PDB format compatible entry.
Summary for 8R8M
Entry DOI10.2210/pdb8r8m/pdb
Related8R6C 9FBV
EMDB information19004
Related PRD IDPRD_002555
DescriptorLarge ribosomal subunit protein bL33, Large ribosomal subunit protein uL6, Large ribosomal subunit protein bL9, ... (60 entities in total)
Functional Keywordsribosome, 70s, paenilamicin, antibiotic
Biological sourceEscherichia coli BW25113
More
Total number of polymer chains56
Total formula weight2201656.74
Authors
Koller, T.O.,Wilson, D.N. (deposition date: 2023-11-29, release date: 2024-07-24)
Primary citationKoller, T.O.,Berger, M.J.,Morici, M.,Paternoga, H.,Bulatov, T.,Di Stasi, A.,Dang, T.,Mainz, A.,Raulf, K.,Crowe-McAuliffe, C.,Scocchi, M.,Mardirossian, M.,Beckert, B.,Vazquez-Laslop, N.,Mankin, A.,Sussmuth, R.D.,Wilson, D.N.
Paenilamicins from the honey bee pathogen Paenibacillus larvae are context-specific translocation inhibitors of protein synthesis.
Biorxiv, 2024
Cited by
PubMed Abstract: The paenilamicins are a group of hybrid non-ribosomal peptide-polyketide compounds produced by the honey bee pathogen that display activity against Gram-positive pathogens, such as . While paenilamicins have been shown to inhibit protein synthesis, their mechanism of action has remained unclear. Here, we have determined structures of the paenilamicin PamB2 stalled ribosomes, revealing a unique binding site on the small 30S subunit located between the A- and P-site tRNAs. In addition to providing a precise description of interactions of PamB2 with the ribosome, the structures also rationalize the resistance mechanisms utilized by . We could further demonstrate that PamB2 interferes with the translocation of mRNA and tRNAs through the ribosome during translation elongation, and that this inhibitory activity is influenced by the presence of modifications at position 37 of the A-site tRNA. Collectively, our study defines the paenilamicins as a new class of context-specific translocation inhibitors.
PubMed: 38826346
DOI: 10.1101/2024.05.21.595107
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.4 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon